The Implications of Obesity as a Disability in Europe
Despite rising obesity in Europe, the EU has yet to approve weight loss drugs from Arena (ARNA), Vivus (VVUS), or Orexigen (OREX).
Arena Pharmaceuticals Inc. Still Down After CEO's Sale
It says something about the short-term prospects for Arena Pharmaceuticals. And competitors, Orexigen and VIVUS, for that matter.
3 Crashing Biotechs: Is 1 a Buy?
Here's why Aegerion (AEGR), Vivus (VVUS), and Exelixis (EXEL) are healthcare's worst performers this year.